🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
PT Charlie Hospital Semarang Tbk (IDX:RSCH)
Indonesia flag Indonesia · Delayed Price · Currency is IDR
248.00
0.00 (0.00%)
At close: Nov 20, 2026

IDX:RSCH Income Statement

Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
118,982114,39748,50242,16033,03335,558
Revenue Growth
102.23%135.86%15.04%27.63%-7.10%168.08%
Cost of Revenue
94,79596,76535,23930,21329,84120,256
Gross Profit
24,18717,63213,26311,9473,19315,302
Selling, General & Admin
18,85416,96612,36713,3648,0497,982
Other Operating Expenses
2,7102,295969.26-1,2491,432
Operating Expenses
32,53828,73316,32113,36411,98811,781
Operating Income
-8,351-11,101-3,058-1,417-8,7963,520
Interest Expense
-5,089-10,434-1,410---
Interest & Investment Income
14.3635.5141.8443.2533.578.91
Other Non Operating Income (Expenses)
955.37597.35361.261.26-152.7721.43
EBT Excluding Unusual Items
-12,470-20,903-4,065-1,312-8,9153,550
Asset Writedown
1,112--24.38---
Pretax Income
-11,358-20,903-4,090-1,312-8,9153,550
Income Tax Expense
-2,394-4,491-577.08-200.68-1,560810.09
Earnings From Continuing Operations
-8,964-16,412-3,512-1,112-7,3552,740
Minority Interest in Earnings
-25.91-8.38----
Net Income
-8,990-16,420-3,512-1,112-7,3552,740
Net Income to Common
-8,990-16,420-3,512-1,112-7,3552,740
Net Income Growth
------
Shares Outstanding (Basic)
2,6502,6502,6502,3031,0001,000
Shares Outstanding (Diluted)
2,6502,6502,6502,3031,0001,000
Shares Change
--15.05%130.33%-1923.39%
EPS (Basic)
-3.39-6.20-1.33-0.48-7.352.74
EPS (Diluted)
-3.39-6.20-1.33-0.48-7.352.74
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
50,977-49,767-40,212-62,216-16,095-12,011
Free Cash Flow Per Share
19.24-18.78-15.17-27.01-16.09-12.01
Gross Margin
20.33%15.41%27.35%28.34%9.66%43.03%
Operating Margin
-7.02%-9.70%-6.31%-3.36%-26.63%9.90%
Profit Margin
-7.56%-14.35%-7.24%-2.64%-22.26%7.71%
Free Cash Flow Margin
42.84%-43.50%-82.91%-147.57%-48.72%-33.78%
EBITDA
4,1168,7575,4094,322-3,2877,916
EBITDA Margin
3.46%7.66%11.15%10.25%-9.95%22.26%
D&A For EBITDA
12,46719,8588,4675,7395,5094,396
EBIT
-8,351-11,101-3,058-1,417-8,7963,520
EBIT Margin
-7.02%-9.70%-6.31%-3.36%-26.63%9.90%
Effective Tax Rate
-----22.82%